title: Impact of inflammation, emphysema, and smoking cessation on V/Q in mouse models of lung obstruction.
abstract: BACKGROUND
  Chronic obstructive pulmonary disease (COPD) is known to greatly affect ventilation (V) and perfusion (Q) of the lung through pathologies such as inflammation and emphysema. However, there is little direct evidence regarding how these pathologies contribute to the V/Q mismatch observed in COPD and models thereof. Also, little is known regarding how smoking cessation affects V/Q relationships after inflammation and airspace enlargement have become established. To this end, we have quantified V/Q on a per-voxel basis using single photon emission computed tomography (SPECT) in mouse models of COPD and lung obstruction.
  
  
  METHODS
  Three distinct murine models were used to investigate the impact of different pathologies on V/Q, as measured by SPECT. Lipopolysaccharide (LPS) was used to produce neutrophilic inflammation, porcine pancreatic elastase (PPE) was used to produce emphysema, and long-term cigarette smoke (CS) exposure and cessation were used to investigate the combination of these pathologies.
  
  
  RESULTS
  CS exposure resulted in an increase in mononuclear cells and neutrophils, an increase in airspace enlargement, and an increase in V/Q mismatching. The inflammation produced by LPS was more robust and predominantly neutrophilic, compared to that of cigarette smoke; nevertheless, inflammation alone caused V/Q mismatching similar to that seen with long-term CS exposure. The emphysematous lesions caused by PPE administration were also capable of causing V/Q mismatch in the absence of inflammation. Following CS cessation, inflammatory cell levels returned to those of controls and, similarly, V/Q measures returned to normal despite evidence of persistent mild airspace enlargement.
  
  
  CONCLUSIONS
  Both robust inflammation and extensive airspace enlargement, on their own, were capable of producing V/Q mismatch. As CS cessation resulted in a return of V/Q mismatching and inflammatory cell counts to control levels, lung inflammation is likely a major contributor to V/Q mismatch observed in the cigarette smoke exposure model as well as in COPD patients. This return of V/Q mismatching to control values also took place in the presence of mild airspace enlargement, indicating that emphysematous lesions must be of a larger volume before affecting the lung significantly. Early smoking cessation is therefore critical before emphysema has an irreversible impact on gas exchange.
authors.forename: Brian N
authors.initials: BN
authors.lastname: Jobse
authors.forename: Cory Ajr
authors.initials: CA
authors.lastname: McCurry
authors.forename: Mathieu C
authors.initials: MC
authors.lastname: Morissette
authors.forename: Rod G
authors.initials: RG
authors.lastname: Rhem
authors.forename: Martin R
authors.initials: MR
authors.lastname: Stämpfli
authors.affiliation: Department of Medicine, Division of Respirology, McMaster University, Hamilton, Canada. labir@mcmaster.ca.
authors.forename: Nancy Renée
authors.initials: NR
authors.lastname: Labiris
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D005260:Female; D051379:Mice; D008807:Mice, Inbred BALB C; D011014:Pneumonia / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D011653:Pulmonary Diffusing Capacity / Q000502:physiology; D029424:Pulmonary Disease, Chronic Obstructive / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D011656:Pulmonary Emphysema / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D012123:Pulmonary Ventilation / Q000502:physiology; D012907:Smoking / Q000009:adverse effects / Q000473:pathology*; D016540:Smoking Cessation; D013552:Swine
references.citation: Eur Respir J. 2010 Nov;36(5):1131-42
references.pmid: 20413532
references.citation: Radiology. 2010 Jul;256(1):280-9
references.pmid: 20574101
references.citation: J Appl Physiol (1985). 2004 Mar;96(3):1127-36
references.pmid: 14617523
references.citation: Respir Res. 2009 Aug 14;10:76
references.pmid: 19682386
references.citation: Am J Respir Crit Care Med. 2009 Apr 15;179(8):666-75
references.pmid: 19179487
references.citation: Respir Res. 2010 Jul 22;11:99
references.pmid: 20649997
references.citation: Ann Nucl Med. 2010 May;24(4):269-77
references.pmid: 20340054
references.citation: Pharmacol Ther. 2011 May;130(2):93-105
references.pmid: 21074553
references.citation: J Clin Invest. 1977 Feb;59(2):203-16
references.pmid: 833271
references.citation: J Appl Physiol (1985). 2008 May;104(5):1462-9
references.pmid: 18356485
references.citation: Clin Respir J. 2011 Oct;5(4):187-94
references.pmid: 21689381
references.citation: Annu Rev Pathol. 2009;4:435-59
references.pmid: 18954287
references.citation: Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55
references.pmid: 17507545
references.citation: Lancet. 2012 Apr 7;379(9823):1341-51
references.pmid: 22314182
references.citation: J Nucl Med. 2013 Apr;54(4):616-23
references.pmid: 23397007
references.citation: Semin Nucl Med. 2010 Nov;40(6):467-73
references.pmid: 20920636
references.citation: PLoS One. 2012;7(8):e42187
references.pmid: 22870297
references.citation: Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1344-52
references.pmid: 21365251
references.citation: Chest. 2011 Jun;139(6):1380-1387
references.pmid: 20966041
references.citation: Am J Respir Cell Mol Biol. 2010 Apr;42(4):394-403
references.pmid: 19502389
references.citation: Semin Nucl Med. 2008 Nov;38(6):441-9
references.pmid: 19331838
references.citation: Am J Respir Crit Care Med. 2010 Sep 1;182(5):598-604
references.pmid: 20522794
references.citation: J Appl Physiol (1985). 2009 Jun;106(6):1902-8
references.pmid: 19372303
references.citation: J Appl Physiol (1985). 1994 May;76(5):2163-8
references.pmid: 8063682